Victory Capital Management
TNYA icon

Victory Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

Victory Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18K Buy
24,395
+5,904
+32% +$4.48K ﹤0.01% 2450
2026
Q1 		$12.8K Buy
18,491
+843
+5% +$622 ﹤0.01% 2389
2025
Q4 		$12.6K Buy
+17,648
New +$24K ﹤0.01% 2404
2025
Q2 		– Sell
-15,299
Closed -$8.72K – 2559
2025
Q1 		$8.72K Buy
+15,299
New +$15.1K ﹤0.01% 2460

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management's TNYA Position: Q2 2026 in Review

Victory Capital Management increased its Tenaya Therapeutics (TNYA) stake by 32% in Q2 2026, buying an estimated $4.48K and bringing the position to 24,395 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #2450.

Victory Capital Management first reported a position in TNYA in Q1 2025 and has held it in 4 quarters since. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Victory Capital Management held 24,395 shares of Tenaya Therapeutics worth $18K as of Q2 2026.
  • Victory Capital Management bought 5,904 Tenaya Therapeutics shares in Q2 2026, an estimated $4.48K.
  • Tenaya Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2450 holding.
  • Victory Capital Management first reported a position in Tenaya Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.